99Tcm-exametazime-labelled leucocytes: Effect of volume and concentration of exametazime on labelling efficiency, and clinical protocol for high efficiency multi-dose radiolabelling

Nuclear Medicine Communications

Volumn 12, Issue 8, 1991, Pages 719-723

  Sampson, C B ^a   Solanki, C ^a   Barber, R W ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKANONE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; TECHNETIUM COMPLEX; RADIOLIGAND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM;

ARTICLE; HUMAN; ISOTOPE LABELING; LEUKOCYTE; METHODOLOGY; CLINICAL PRACTICE; DRUG CONCENTRATION; ENTERITIS; HUMAN CELL; INCUBATION TIME; LEUKOCYTE COUNT; LIGAND BINDING; TEMPERATURE SENSITIVITY;

BUTANONES; HUMAN; ISOTOPE LABELING; LEUKOCYTES; ORGANOTECHNETIUM COMPOUNDS; TECHNETIUM TC 99M EXAMETAZIME;

EID: 0025918010     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-199108000-00007     Document Type: Article

References (14)

1. Roddie ME, Peters AM, Danpure H, Osman S. Imaging with Tc-99m HM-PAO labelled leucocytes. Radiology 1988; 166: 767-72.
2. Mortelmans L. Clinical usefulness of Tc-99m HM-PAO labelled white blood cell imaging in abscesses. Clin Nucl Med 1989; 14: 127-30.
3. Becker W. Radiolabelled granulocytes in inflammatory bowel disease: diagnostic possibilities and clinical indications. Nucl Med Commttn 1988; 9: 693-6.
4. Scholmerich J, Schmidt E, Schmichen C, Bilman T. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using Tc-99m HM-PAO as a leucocyte label. Gastroenterology 1988; 95: 1287-93.
5. Roddie ME, Peters AM, Osman S, Danpure H. Osteomyelitis. Nucl Med Commun 1988; 9: 713-18.
6. Peters AM. Sepsis. Nucl Med Commun 1988; 9: 719-23.
7. Reynolds JH, Graham D, Smith FW. Imaging inflammation with Tc-99m HM-PAO labelled leucocytes. Clin Radiol 1990; 42: 195-8.
8. Danpure HJ, Osman S, Carroll MJ. In-vivo studies to develop a clinical protocol for radiolabelling mixed leucocytes with Tc-99m HM-PAO. Nucl Med Commun 1987; 8: 280-3.
9. Solanki KK, Mather SJ, Janabi M, Britton KE. A rapid method for the preparation of Tc-99m exametazime labelled leucocytes. Nucl Med Commun 1988; 9: 753-61.
10. Danpure HJ, Osman S, Brady F. The labelling of blood cells in plasma with In-111 tropolonate. Br J Radiol 1982; 55: 247-9.
11. Danpure HJ, Osman S. Specifications and quality control methods for labelling cells. In: Kristensen K, Norbygard F, eds. Safety and efficacy of radiopharmaceuticals. Martinus Nijhoff 1987; 161-87.
12. Ballinger J. Preparation of technetium-99m HMPAO. J Nucl Med 1990; 31: 1892.
13. Li DJ, Middleton SJ, Wraight EP. Tc-99m HMPAO-labelled leucocyte scintigraphy in inflammatory bowel disease. Nucl Med Commun 1990; 11: 889.
14. Allan RA, Sladen GE, Bassingham S et al. Tc-99m HMPAO and In-111 labelled white cell scans in assessment of inflammatory bowel disease. Nucl Med Commun 1990; 11: 890.